Rapid Resolution of Recalcitrant Headache With Pasireotide in an Adult Patient With Acromegaly.
Zeinab DabbousZaina RohaniAbeer Kaled AbdalrubbYaman AlkailaniRosario PivonelloTarik ElhaddPublished in: JCEM case reports (2024)
Acromegaly is a chronic hormonal disorder caused by excessive GH secretion. In addition to physiological symptoms, it is often accompanied by debilitating headaches. Although effective treatment options exist, achieving complete symptom control and disease management can still be challenging. This case report chronicles the clinical journey of a 38-year-old male diagnosed with acromegaly in 2013. Despite prior interventions, including surgery and treatment with first-generation somatostatin analogues, severe frequent headaches persisted. Following a switch to pasireotide, the patient reported rapid and complete resolution of headaches and normalization of IGF-1 levels within a month of the treatment switch. This report underscores the challenges in acromegaly management and confirms the potential utility of pasireotide for patients suffering from treatment-resistant headache.
Keyphrases
- patient reported
- case report
- growth hormone
- end stage renal disease
- ejection fraction
- minimally invasive
- single molecule
- newly diagnosed
- type diabetes
- prognostic factors
- physical activity
- combination therapy
- depressive symptoms
- coronary artery disease
- adipose tissue
- climate change
- signaling pathway
- atrial fibrillation
- sleep quality
- pi k akt
- insulin resistance
- drug induced